Skip to main content
Top
Published in: AIDS Research and Therapy 1/2007

Open Access 01-12-2007 | Research

Instability of retroviral vectors with HIV-1-specific RT aptamers due to cryptic splice sites in the U6 promoter

Authors: Stephen E Braun, Xuanling Shi, Gang Qiu, Fay Eng Wong, Pheroze J Joshi, Vinayaka R Prasad, RPaul Johnson

Published in: AIDS Research and Therapy | Issue 1/2007

Login to get access

Abstract

Background

Internal polymerase III promoters in retroviral vectors have been used extensively to express short RNA sequences, such as ribozymes, RNA aptamers or short interfering RNA inhibitors, in various positions and orientations. However, the stability of these promoters in the reverse orientation has not been rigorously evaluated.

Results

A series of retroviral vectors was generated carrying the U6+1 promoter with 3 different HIV-1 RT-specific RNA aptamers and one control aptamer, all in the reverse orientation. After shuttle packaging, the CD4+ cell line CEMx174 was transduced with each vector, selected for expression of GFP, and challenged with HIV-1. We did not observe inhibition of HIV-1 replication in these transduced populations. PCR amplification of the U6+1 promoter-RNA aptamer inhibitor cassette from transduced CEMx174 cells and RT-PCR amplification from transfected Phoenix (amphotropic) packaging cells showed two distinct products: a full-length product of the expected size as well as a truncated product. The sequence of the full-length PCR product was identical to the predicted amplicon sequence. However, sequencing of the truncated product revealed a 139 bp deletion in the U6 promoter. This deletion decreased transcriptional activity of the U6 promoter. Analysis of the deleted sequences from the U6 promoter in the antisense direction indicated consensus splice donor, splice acceptor and branch point sequences.

Conclusion

The existence of a cryptic splice site in the U6 promoter when expressed in a retroviral vector in the reverse orientation generates deletions during packaging and may limit the utility of this promoter for expression of small RNA inhibitors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ilves H, Barske C, Junker U, Bohnlein E, Veres G: Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study. Gene. 1996, 171 (2): 203-208. 10.1016/0378-1119(96)00075-3CrossRefPubMed Ilves H, Barske C, Junker U, Bohnlein E, Veres G: Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study. Gene. 1996, 171 (2): 203-208. 10.1016/0378-1119(96)00075-3CrossRefPubMed
2.
go back to reference Chang Z, Westaway S, Li S, Zaia JA, Rossi JJ, Scherer LJ: Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters. Mol Ther. 2002, 6 (4): 481-489. 10.1006/mthe.2002.0696CrossRefPubMed Chang Z, Westaway S, Li S, Zaia JA, Rossi JJ, Scherer LJ: Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters. Mol Ther. 2002, 6 (4): 481-489. 10.1006/mthe.2002.0696CrossRefPubMed
3.
go back to reference Paul CP, Good PD, Li SX, Kleihauer A, Rossi JJ, Engelke DR: Localized expression of small RNA inhibitors in human cells. Mol Ther. 2003, 7 (2): 237-247. 10.1016/S1525-0016(02)00038-2CrossRefPubMed Paul CP, Good PD, Li SX, Kleihauer A, Rossi JJ, Engelke DR: Localized expression of small RNA inhibitors in human cells. Mol Ther. 2003, 7 (2): 237-247. 10.1016/S1525-0016(02)00038-2CrossRefPubMed
4.
go back to reference Li MJ, Bauer G, Michienzi A, Yee JK, Lee NS, Kim JH, Li S, Castanotto D, Zaia JA, Rossi JJ: Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther. 2003, 8 (2): 196-206. 10.1016/S1525-0016(03)00165-5CrossRefPubMed Li MJ, Bauer G, Michienzi A, Yee JK, Lee NS, Kim JH, Li S, Castanotto D, Zaia JA, Rossi JJ: Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther. 2003, 8 (2): 196-206. 10.1016/S1525-0016(03)00165-5CrossRefPubMed
5.
go back to reference Michienzi A, Cagnon L, Bahner I, Rossi JJ: Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA. Proc Natl Acad Sci U S A. 2000, 97 (16): 8955-8960. 10.1073/pnas.97.16.8955PubMedCentralCrossRefPubMed Michienzi A, Cagnon L, Bahner I, Rossi JJ: Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA. Proc Natl Acad Sci U S A. 2000, 97 (16): 8955-8960. 10.1073/pnas.97.16.8955PubMedCentralCrossRefPubMed
6.
go back to reference Miller AD, Bender MA, Harris EA, Kaleko M, Gelinas RE: Design of retrovirus vectors for transfer and expression of the human beta-globin gene. J Virol. 1988, 62 (11): 4337-4345.PubMedCentralPubMed Miller AD, Bender MA, Harris EA, Kaleko M, Gelinas RE: Design of retrovirus vectors for transfer and expression of the human beta-globin gene. J Virol. 1988, 62 (11): 4337-4345.PubMedCentralPubMed
7.
go back to reference Jonsson JJ, Habel DE, McIvor RS: Retrovirus-mediated transduction of an engineered intron-containing purine nucleoside phosphorylase gene. Hum Gene Ther. 1995, 6 (5): 611-623.CrossRefPubMed Jonsson JJ, Habel DE, McIvor RS: Retrovirus-mediated transduction of an engineered intron-containing purine nucleoside phosphorylase gene. Hum Gene Ther. 1995, 6 (5): 611-623.CrossRefPubMed
8.
go back to reference Sorrentino BP, McDonagh KT, Woods D, Orlic D: Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood. 1995, 86 (2): 491-501.PubMed Sorrentino BP, McDonagh KT, Woods D, Orlic D: Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood. 1995, 86 (2): 491-501.PubMed
9.
go back to reference Pathak VK, Temin HM: Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A. 1990, 87 (16): 6024-6028. 10.1073/pnas.87.16.6024PubMedCentralCrossRefPubMed Pathak VK, Temin HM: Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A. 1990, 87 (16): 6024-6028. 10.1073/pnas.87.16.6024PubMedCentralCrossRefPubMed
10.
go back to reference McIvor RS: Deletion in a recombinant retroviral vector resulting from a cryptic splice donor signal in the Moloney leukemia virus envelope gene. Virology. 1990, 176 (2): 652-655. 10.1016/0042-6822(90)90039-TCrossRefPubMed McIvor RS: Deletion in a recombinant retroviral vector resulting from a cryptic splice donor signal in the Moloney leukemia virus envelope gene. Virology. 1990, 176 (2): 652-655. 10.1016/0042-6822(90)90039-TCrossRefPubMed
11.
go back to reference Joshi PJ, North TW, Prasad VR: Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication. Mol Ther. 2005, 11 (5): 677-686. 10.1016/j.ymthe.2005.01.013CrossRefPubMed Joshi PJ, North TW, Prasad VR: Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication. Mol Ther. 2005, 11 (5): 677-686. 10.1016/j.ymthe.2005.01.013CrossRefPubMed
12.
go back to reference Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Grignani F, Lanfrancone L, Peschle C, Nolan GP, Pelicci PG: High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 1998, 58 (1): 14-19.PubMed Grignani F, Kinsella T, Mencarelli A, Valtieri M, Riganelli D, Grignani F, Lanfrancone L, Peschle C, Nolan GP, Pelicci PG: High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 1998, 58 (1): 14-19.PubMed
13.
go back to reference Horn PA, Topp MS, Morris JC, Riddell SR, Kiem HP: Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells. Blood. 2002, 100 (12): 3960-3967. 10.1182/blood-2002-05-1359CrossRefPubMed Horn PA, Topp MS, Morris JC, Riddell SR, Kiem HP: Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells. Blood. 2002, 100 (12): 3960-3967. 10.1182/blood-2002-05-1359CrossRefPubMed
14.
go back to reference Faustino NA, Cooper TA: Pre-mRNA splicing and human disease. Genes Dev. 2003, 17 (4): 419-437. 10.1101/gad.1048803CrossRefPubMed Faustino NA, Cooper TA: Pre-mRNA splicing and human disease. Genes Dev. 2003, 17 (4): 419-437. 10.1101/gad.1048803CrossRefPubMed
15.
16.
go back to reference Gardner EJ, Simmons MJ, Snustad DP: Principles of Genetics. 1991, New York, Chichester, Brisbane, Toronto, Singapore , John Wiley & Sons, Inc., Eighth Edition, Gardner EJ, Simmons MJ, Snustad DP: Principles of Genetics. 1991, New York, Chichester, Brisbane, Toronto, Singapore , John Wiley & Sons, Inc., Eighth Edition,
17.
go back to reference Murphy S, Yoon JB, Gerster T, Roeder RG: Oct-1 and Oct-2 potentiate functional interactions of a transcription factor with the proximal sequence element of small nuclear RNA genes. Mol Cell Biol. 1992, 12 (7): 3247-3261.PubMedCentralCrossRefPubMed Murphy S, Yoon JB, Gerster T, Roeder RG: Oct-1 and Oct-2 potentiate functional interactions of a transcription factor with the proximal sequence element of small nuclear RNA genes. Mol Cell Biol. 1992, 12 (7): 3247-3261.PubMedCentralCrossRefPubMed
18.
go back to reference Hernandez N: Small nuclear RNA genes: a model system to study fundamental mechanisms of transcription. J Biol Chem. 2001, 276 (29): 26733-26736. 10.1074/jbc.R100032200CrossRefPubMed Hernandez N: Small nuclear RNA genes: a model system to study fundamental mechanisms of transcription. J Biol Chem. 2001, 276 (29): 26733-26736. 10.1074/jbc.R100032200CrossRefPubMed
19.
go back to reference Danzeiser DA, Urso O, Kunkel GR: Functional characterization of elements in a human U6 small nuclear RNA gene distal control region. Mol Cell Biol. 1993, 13 (8): 4670-4678.PubMedCentralCrossRefPubMed Danzeiser DA, Urso O, Kunkel GR: Functional characterization of elements in a human U6 small nuclear RNA gene distal control region. Mol Cell Biol. 1993, 13 (8): 4670-4678.PubMedCentralCrossRefPubMed
20.
go back to reference Schaub M, Myslinski E, Schuster C, Krol A, Carbon P: Staf, a promiscuous activator for enhanced transcription by RNA polymerases II and III. Embo J. 1997, 16 (1): 173-181. 10.1093/emboj/16.1.173PubMedCentralCrossRefPubMed Schaub M, Myslinski E, Schuster C, Krol A, Carbon P: Staf, a promiscuous activator for enhanced transcription by RNA polymerases II and III. Embo J. 1997, 16 (1): 173-181. 10.1093/emboj/16.1.173PubMedCentralCrossRefPubMed
21.
go back to reference Mittal V, Cleary MA, Herr W, Hernandez N: The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPc. Mol Cell Biol. 1996, 16 (5): 1955-1965.PubMedCentralPubMed Mittal V, Cleary MA, Herr W, Hernandez N: The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPc. Mol Cell Biol. 1996, 16 (5): 1955-1965.PubMedCentralPubMed
22.
go back to reference Zhao X, Pendergrast PS, Hernandez N: A positioned nucleosome on the human U6 promoter allows recruitment of SNAPc by the Oct-1 POU domain. Mol Cell. 2001, 7 (3): 539-549. 10.1016/S1097-2765(01)00201-5CrossRefPubMed Zhao X, Pendergrast PS, Hernandez N: A positioned nucleosome on the human U6 promoter allows recruitment of SNAPc by the Oct-1 POU domain. Mol Cell. 2001, 7 (3): 539-549. 10.1016/S1097-2765(01)00201-5CrossRefPubMed
23.
go back to reference Banerjea AC, Li MJ, Bauer G, Remling L, Lee NS, Rossi J, Akkina R: Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol Ther. 2003, 8 (1): 62-71. 10.1016/S1525-0016(03)00140-0CrossRefPubMed Banerjea AC, Li MJ, Bauer G, Remling L, Lee NS, Rossi J, Akkina R: Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol Ther. 2003, 8 (1): 62-71. 10.1016/S1525-0016(03)00140-0CrossRefPubMed
24.
go back to reference Qin XF, An DS, Chen IS, Baltimore D: Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A. 2003, 100 (1): 183-188. 10.1073/pnas.232688199PubMedCentralCrossRefPubMed Qin XF, An DS, Chen IS, Baltimore D: Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A. 2003, 100 (1): 183-188. 10.1073/pnas.232688199PubMedCentralCrossRefPubMed
25.
go back to reference Johnson VA, Walker BD: HIV-infected cell fusion assay. Techniques in HIV research. Edited by: Walker AABD. 1990, 92-94. New York , Stockton Press, Johnson VA, Walker BD: HIV-infected cell fusion assay. Techniques in HIV research. Edited by: Walker AABD. 1990, 92-94. New York , Stockton Press,
26.
go back to reference Worley KC, Culpepper P, Wiese BA, Smith RF: BEAUTY-X: enhanced BLAST searches for DNA queries. Bioinformatics. 1998, 14 (10): 890-891. 10.1093/bioinformatics/14.10.890CrossRefPubMed Worley KC, Culpepper P, Wiese BA, Smith RF: BEAUTY-X: enhanced BLAST searches for DNA queries. Bioinformatics. 1998, 14 (10): 890-891. 10.1093/bioinformatics/14.10.890CrossRefPubMed
27.
go back to reference Huang X: On global sequence alignment. Comput Appl Biosci. 1994, 10 (3): 227-235.PubMed Huang X: On global sequence alignment. Comput Appl Biosci. 1994, 10 (3): 227-235.PubMed
28.
go back to reference Lin X, Yang J, Chen J, Gunasekera A, Fesik SW, Shen Y: Development of a tightly regulated U6 promoter for shRNA expression. FEBS Lett. 2004, 577 (3): 376-380. 10.1016/j.febslet.2004.10.033CrossRefPubMed Lin X, Yang J, Chen J, Gunasekera A, Fesik SW, Shen Y: Development of a tightly regulated U6 promoter for shRNA expression. FEBS Lett. 2004, 577 (3): 376-380. 10.1016/j.febslet.2004.10.033CrossRefPubMed
Metadata
Title
Instability of retroviral vectors with HIV-1-specific RT aptamers due to cryptic splice sites in the U6 promoter
Authors
Stephen E Braun
Xuanling Shi
Gang Qiu
Fay Eng Wong
Pheroze J Joshi
Vinayaka R Prasad
RPaul Johnson
Publication date
01-12-2007
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2007
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/1742-6405-4-24

Other articles of this Issue 1/2007

AIDS Research and Therapy 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.